Overview
Researchers at the JNCASR, Bengaluru, have created a new imaging platform called CLEAR. The technique lets scientists map dozens of proteins in the same cell or tissue using only one fluorophore. By erasing the fluorescent signal with a gentle 365 nm light pulse, a new set of proteins can be labelled and imaged in the same optical window, enabling virtually unlimited protein visualization.
Key Developments
- Design and synthesis of CLEAR probes by Prof. Sarit S. Agasti and team.
- Demonstration of high‑plex imaging on immune cells in collaboration with IISc researchers.
- Implementation of a light‑cleavable probe system that allows repeated cycles of labelling and imaging within the same spectral window.
- Publication of the method in Chemical Science (Royal Society of Chemistry).
Important Facts
- The platform works like a chalkboard: after imaging a set of proteins, a 365 nm LED pulse erases the fluorescence, freeing the same channel for the next set.
- It is compatible with delicate samples, including live cells, unlike many existing multiplexing techniques.
- Potential applications span cancer biology, immunology, and neurological disorders where spatial protein organization is critical.
- By providing high‑resolution, spatially resolved protein maps, CLEAR supports early disease detection and precision‑medicine approaches.
Exam Relevance
The development showcases the role of the DST in fostering cutting‑edge research that can translate into public health benefits. Understanding multiplexed imaging and spatial proteomics is essential for answering questions on disease diagnostics, a topic frequently asked in GS3 (Science & Technology) and GS4 (Ethics) papers. The technology also illustrates how Indian research institutions can contribute to global scientific challenges, a point relevant to GS2 (Polity) discussions on science policy.
Way Forward
To move from laboratory proof‑of‑concept to clinical use, the following steps are needed:
- Scale‑up of probe production and standardisation of the imaging workflow.
- Validation on larger patient cohorts, especially for cancer and neuro‑degenerative diseases.
- Integration with existing pathology labs and training of technicians.
- Policy support from the DST to fund translational studies and create regulatory guidelines for spatial proteomics diagnostics.
Successful implementation could accelerate India's precision‑medicine agenda and improve early detection of life‑threatening diseases.